Advances in the management of irritable bowel syndrome.

John E Kellow

Journal: Journal of gastroenterology and hepatology 2002;17(4):503-7

PMID: 11982734

Abstract

Recent advances in different aspects of irritable bowel syndrome have led to a need to reassess the overall management of this common, complex disorder. Important areas include: first, the heterogeneity of symptom patterns and the role of specific diagnostic symptom criteria for use in both clinical practice and in clinical research; second, the growing interest in the potential interaction between "peripheral" and "central" pathophysiological mechanisms; and third, the development of novel and effective drugs designed to target specific receptor systems in the enteric nervous system. This review covers each of these aspects and emphasizes an approach to management of patients based on pathophysiological considerations.

Copyright 2002 Blackwell Publishing Asia Pty Ltd

Address: Department of Medicine, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.